STOCK TITAN

Versigent (NYSE: VGNT) posts Q1 2026 results, sets dividend and $250M buyback

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Versigent PLC reported mixed but generally solid first quarter 2026 results and outlined a new capital return strategy. Revenue reached $2,212 million, up 9% year over year, or 3% after adjusting for currency and commodity movements, driven by higher volumes in North America and Asia Pacific.

Net income attributable to Versigent was $78 million, down from $95 million a year earlier, while Adjusted EBITDA edged up to $203 million with a margin of 9.2% versus 9.8% previously. Free cash flow was $(30) million, including $26 million of separation costs related to the spin-off from Aptiv.

For full-year 2026, Versigent reaffirmed guidance, targeting revenue of $9,100–$9,400 million, U.S. GAAP net income of $315–$375 million, Adjusted EBITDA of $950–$1,030 million, operating cash flow of $440–$540 million and free cash flow of $200–$300 million. The board approved a dividend policy aiming for $0.13 per share quarterly and authorized a share repurchase program of up to $250 million, underscoring an emphasis on disciplined capital allocation after the spin-off.

Positive

  • Reaffirmed 2026 guidance with sizable earnings targets: Versigent maintained full-year 2026 outlook, including revenue of $9.1–$9.4 billion, U.S. GAAP net income of $315–$375 million, Adjusted EBITDA of $950–$1,030 million, and free cash flow of $200–$300 million.
  • Introduced dividend and buyback framework: The board approved a dividend policy targeting approximately $0.13 per share quarterly and authorized a share repurchase program for up to $250 million of shares, highlighting a clear capital return approach post spin-off.
  • Top-line growth despite industry headwinds: Q1 2026 revenue grew 9% to $2,212 million, or 3% on an adjusted basis, driven by higher volumes in North America and Asia Pacific even as global automotive production was lower.

Negative

  • Profitability and cash flow pressure in the quarter: Net income attributable to Versigent declined to $78 million from $95 million, Adjusted EBITDA margin slipped from 9.8% to 9.2%, and free cash flow was negative $30 million due to higher restructuring, separation costs and capital expenditures.
  • Leverage increased with new long-term debt: Long-term debt rose to $2,074 million as of March 31, 2026, from $3 million at December 31, 2025, reflecting new senior notes and a credit agreement associated with the spin-off.

Insights

Versigent posted solid revenue growth, reaffirmed 2026 guidance, and introduced meaningful capital return plans.

Versigent generated Q1 2026 revenue of $2,212 million, up 9%, with 3% adjusted growth once currency and commodity effects are stripped out. Adjusted EBITDA rose slightly to $203 million, though the margin eased to 9.2% from 9.8%, reflecting higher restructuring and separation costs.

Net income attributable to Versigent declined to $78 million from $95 million, and free cash flow turned negative at $(30) million, including $26 million of separation costs. The balance sheet shows significantly higher long-term debt of $2,074 million as of March 31, 2026, consistent with financing put in place around the spin-off.

Despite these near-term costs, Versigent reaffirmed its 2026 outlook, guiding to revenue of $9,100–$9,400 million and Adjusted EBITDA of $950–$1,030 million. The board’s approval of a dividend policy targeting $0.13 per share quarterly and a $250 million share repurchase program signals confidence in cash generation over 2026, assuming execution in line with the guidance ranges.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Q1 2026 Revenue $2,212 million Three months ended March 31, 2026; up 9% year over year
Q1 2026 Net Income attributable to Versigent $78 million Three months ended March 31, 2026; down from $95 million in 2025
Q1 2026 Adjusted EBITDA $203 million Three months ended March 31, 2026; margin 9.2% vs 9.8% prior-year
Q1 2026 Free Cash Flow -$30 million Includes $26 million of separation costs in the quarter
Full-year 2026 Revenue Guidance $9,100–$9,400 million Reaffirmed full-year 2026 outlook
Full-year 2026 Adjusted EBITDA Guidance $950–$1,030 million Reaffirmed full-year 2026 Adjusted EBITDA range
Dividend Policy Target $0.13 per share quarterly Board-approved dividend policy; initial dividend to be declared later
Share Repurchase Authorization $250 million Maximum aggregate amount under new share repurchase program
Adjusted EBITDA financial
"Adjusted EBITDA for the First Quarter 2026 totaled $203 million, compared to $198 million in the prior‑year period."
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Free cash flow financial
"Free cash flow was $(30) million for the First Quarter 2026, compared to $3 million in the prior-year period."
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
Adjusted Revenue Growth financial
"Adjusted for the impact of foreign currency exchange and commodity pass‑through, revenue increased approximately 3% during the First Quarter 2026."
Separation costs financial
"Free cash flow of $(30) million which includes $26 million of separation costs"
Spin-Off financial
"in connection with the Spin-Off"
A spin-off happens when a company creates a new, independent business by separating part of itself, like splitting off a division into its own company. This often happens so the new company can focus better on its own goals or attract different investors. It matters because it can lead to more growth opportunities and clearer focus for both companies.
share repurchase program financial
"Versigent’s board of directors approved a share repurchase program for up to $250 million of the Company’s shares."
A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.
Revenue $2,212 million +9% year over year
Net income attributable to Versigent $78 million down from $95 million prior-year
Adjusted EBITDA $203 million up from $198 million prior-year
Adjusted EBITDA margin 9.2% down from 9.8% prior-year
Free cash flow -$30 million down from $3 million prior-year
Guidance

Reaffirmed full-year 2026 guidance: revenue $9,100–$9,400 million, U.S. GAAP net income $315–$375 million, Adjusted EBITDA $950–$1,030 million, operating cash flow $440–$540 million, free cash flow $200–$300 million.

0002078008false00020780082026-05-052026-05-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________________________________________________________________________

FORM 8-K
________________________________________________________________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 5, 2026
________________________________________________________________________________________________________________________
Versigent PLC
(Exact name of registrant as specified in its charter)
________________________________________________________________________________________________________________________
Jersey001-4295798-1868085
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
Spitalstrasse 5, 8200 Schaffhausen, Switzerland
(Address of Principal Executive Offices, Including Zip Code)
+41 52 580 97 00
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report) N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Ordinary Shares, $0.01 par value per shareVGNTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02    Results of Operations and Financial Condition.
On May 5, 2026, Versigent PLC (the “Company”) issued a press release reporting its financial results for the quarter ended March 31, 2026. A copy of the press release is attached as an exhibit and is incorporated herein by reference. The press release and teleconference visual presentation are available on the Company’s website at versigent.com.
The information in this Item 2.02 and Item 9.01, including Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act.
Item 9.01    Financial Statements and Exhibits.
(d)  Exhibits.
Exhibit
NumberDescription
99.1
Press Release Dated May 5, 2026
104Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded with the Inline XBRL document

2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:May 5, 2026 Versigent PLC
 
 By:/s/ Doug Ostermann
Doug Ostermann
Senior Vice President and Chief Financial Officer

3


EXHIBIT INDEX
Exhibit
NumberDescription
99.1
Press Release Dated May 5, 2026
104Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded with the Inline XBRL document

4
imagea.jpg
PRESS RELEASE




Versigent Reports First Quarter 2026 Results

Strong Revenue Growth, Reaffirmed 2026 Guidance, and Introduction of Dividend Policy and Share Repurchase Program

SCHAFFHAUSEN, Switzerland, May 5, 2026 – Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its first quarter ended March 31, 2026 (“First Quarter 2026”).

Versigent operated as the Electrical Distribution Systems segment of Aptiv PLC (“Aptiv” or the “Parent”) for the entire first quarter of 2026 prior to the distribution of all of the ordinary shares of Versigent to holders of Aptiv’s ordinary shares on a pro rata basis on April 1, 2026 (the “Separation” or “Spin-Off”). Financial information presented for periods prior to April 1, 2026, have been derived from Aptiv’s accounting records and are presented on a carve‑out basis as if Versigent had operated as a standalone company for all periods presented.

First Quarter 2026 Highlights
Revenue of $2,212 million, an increase of 9%
Revenue increased 3% adjusted for currency exchange and commodity movements
Net income attributable to Versigent of $78 million
Adjusted EBITDA of $203 million; Adjusted EBITDA margin of 9.2%
Cash from operations of $36 million; Free cash flow of $(30) million which includes $26 million of separation costs

Full Year 2026 Guidance
Revenue of $9,100 million to $9,400 million; ~2% of adjusted revenue growth
U.S. GAAP net income of $315 million to $375 million
Adjusted EBITDA of $950 million to $1,030 million
Cash flow from operations of $440 million to $540 million
Free cash flow of $200 million to $300 million

“Versigent delivered strong financial results for the quarter reflecting customer demand for our differentiated solutions made possible by our commitment to disciplined operational execution,” said Joe Liotine, Chief Executive Officer, Versigent. “We entered the public markets with clarity about who we are, how we compete, and the opportunities ahead of us to unlock greater value. Versigent launched from a position of strength as a scaled, profitable, and fundamentally resilient business. Our First Quarter 2026 results underscore our commitment to execute consistently, design the right solutions for our customers and create long-term value for our stakeholders around the globe”.

“In the first quarter, Versigent remained focused and executed against our strategy, resulting in solid financial performance including increased revenue, a strong net income attributable to Versigent of $78 million and adjusted EBITDA of $203 million with adjusted EBITDA margins of 9.2%,” said Doug Ostermann, Chief Financial Officer, Versigent. “We continue to operate as a highly-engineered, cash-generative business anchored by our disciplined capital allocation strategy prioritizing the right investments in our business and attractive returns for our shareholders”.

First Quarter 2026 Results
Revenue for the First Quarter 2026 was $2,212 million, an increase of 9% compared to the prior‑year period. Adjusted for the impact of foreign currency exchange and commodity pass‑through, revenue increased approximately 3% during the First Quarter 2026. Growth was driven by higher volumes in North America and Asia Pacific reflecting stronger customer demand despite lower global automotive production.

Net income attributable to Versigent was $78 million, compared to $95 million in the prior‑year period.

Adjusted EBITDA for the First Quarter 2026 totaled $203 million, compared to $198 million in the prior‑year period. Adjusted EBITDA margin was 9.2%, compared to 9.8% in the prior‑year period. Adjusted EBITDA margin reflected disciplined operating execution and higher volumes, despite headwinds related to commodity costs and foreign exchange impacts.














Interest expense for the First Quarter 2026 totaled $5 million, compared to $2 million in the prior‑year period. The increase was related to the issuance of the Company’s Senior Notes and Credit Agreement in connection with the Spin-Off.

Income tax benefit for the First Quarter 2026 was $9 million, compared to income tax expense of $29 million in the prior‑year period. The change primarily reflected discrete tax benefits recognized during the First Quarter 2026.
Net cash provided by operating activities for the First Quarter 2026 was $36 million, compared to $40 million in the prior-year period, reflecting earnings performance partially offset by working capital investment during the period. Capital expenditures totaled $66 million for the First Quarter 2026. Free cash flow was $(30) million for the First Quarter 2026, compared to $3 million in the prior-year period. The decrease in free cash flow compared to the prior-year period was primarily driven by an increase in restructuring costs, one-time separation costs and capital expenditures during the First Quarter 2026.

Capital Allocation
Versigent remains committed to a disciplined and balanced capital allocation framework, prioritizing continued growth, maintaining a strong balance sheet, and returning cash to shareholders. In April 2026, Versigent’s board of directors approved a dividend policy, under which the Company intends to return a portion of future earnings to shareholders in the range of $0.13 per share quarterly, with the initial dividend expected to be declared at a future date. Any dividends will only be payable when, as, and if declared by the board of directors. In addition, Versigent’s board of directors approved a share repurchase program for up to $250 million of the Company’s shares. This repurchase program does not have an expiration date and may be amended, suspended, or terminated by the board of directors at any time. Under the repurchase program, the Company intends to purchase shares from time to time on the open market. The number of shares ultimately purchased, and the timing of purchases are at the discretion of management and subject to compliance with applicable laws and regulations.

2026 Outlook
Versigent reaffirmed its full-year 2026 financial guidance as follows:

(in millions)Full-Year 2026
Revenue$9,100 - $9,400
U.S. GAAP net income$315 - $375
Adjusted EBITDA$950 - $1,030
Cash flow from operations$440 - $540
Free cash flow$200 - $300

Conference Call and Webcast
Versigent will host a conference call to discuss its First Quarter 2026 financial results today, Tuesday, May 5, 2026, at 4:15 p.m. Eastern Time.

A live webcast of the conference call and related presentation materials are available on Versigent’s Investor Relations website at ir.versigent.com. A replay of the webcast will be available approximately two hours following the conclusion of the call.

To participate by telephone, please dial +1‑800‑330‑6710 (U.S.) or +1‑213‑279‑1505 (international) at least 15 minutes prior to the start of the call and reference the Versigent conference call. The conference ID number is 8379126.

About Versigent
Versigent is a global leader in the purposeful design and advanced manufacturing of low and high voltage electrical architectures. Building on a legacy of engineering excellence and trusted partnerships, Versigent delivers versatile, intelligent solutions engineered to unlock greater capabilities for our customers. Powering one in six passenger vehicles in production today, Versigent’s high performance signal, power, and data distribution systems are trusted by industry leaders across automotive, commercial vehicles, agriculture and energy storage. With engineering and manufacturing centers on four continents and operations in more than 25 countries, Versigent’s 138,000 employees match global scale with regional responsiveness to deliver consistent quality and reliable performance connecting the world to faster, smarter and safer experiences. Visit www.versigent.com.

Use of Non‑GAAP Financial Information

2


This press release contains information about Versigent’s financial results which are not presented in accordance with GAAP. Specifically, Adjusted Revenue Growth, Adjusted EBITDA and Free Cash Flow are non-GAAP financial measures. Adjusted Revenue Growth represents the change in reported net sales relative to the comparable period, excluding the impact on net sales from currency exchange and commodity movements. Adjusted EBITDA represents net income (loss) before depreciation and amortization (including asset impairments), interest expense, income tax (expense) benefit, other income (expense), net, equity income (loss), net of tax, restructuring, separation costs related to the Spin-Off and other special items. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of net sales. Free Cash Flow represents cash provided by (used in) operating activities less capital expenditures.

Management believes the non-GAAP financial measures used in this press release are useful to both management and investors in their analysis of the Company’s financial position, results of operations and liquidity. In particular, management believes Adjusted Revenue Growth, Adjusted EBITDA and Free Cash Flow are useful measures in assessing the Company’s ongoing financial performance that, when reconciled to the corresponding GAAP measure, provide improved comparability between periods through the exclusion of certain items that management believes are not indicative of the Company’s core operating performance and that may obscure underlying business results and trends. Management also uses these non-GAAP financial measures for internal planning and forecasting purposes.

Such non-GAAP financial measures are reconciled to the most directly comparable GAAP financial measures in the attached supplemental schedules at the end of this press release. Non-GAAP measures should not be considered in isolation or as a substitute for our reported results prepared in accordance with GAAP and, as calculated, may not be comparable to other similarly titled measures of other companies.

Forward‑Looking Statements
This press release contains forward-looking statements that reflect, when made, Versigent’s current views with respect to current events, business plans and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to Versigent’s operations and business environment, which may cause the actual results of Versigent to be materially different from any future results. All statements that address future operating, financial or business performance or Versigent’s strategies or expectations are forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following: disruptions in the supply of raw materials and other supplies integral to our products; future significant public health crises and other global health crises and the measures taken in response thereto; a prolonged recession and/or a downturn in global automotive sales; the volatile global economic environment and geopolitical conditions, including conditions affecting the credit market and global inflationary pressures; our reliance on relationships with collaborative partners and other third parties for product development and such parties’ failure to perform; employee strikes and labor-related disruptions involving us or one or more of our customers affecting our operations; fluctuations in interest rates and foreign currency exchange rates; our failure to comply with the numerous laws and regulations to which we are subject; adverse developments affecting one or more of our suppliers; any adverse impact of legal proceedings and disputes in which we are involved; challenges to our historical and future tax positions by taxing authorities; an increase in our tax burden due to ongoing or future tax audits; our failure to attract and retain key salaried employees and management personnel; our failure to manage the transition to a standalone public company; our failure to achieve some or all of the benefits expected from the Spin-Off and other risks related to the completion of the Spin-Off. Additional factors are discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Versigent’s filings with the Securities and Exchange Commission. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect Versigent. Versigent disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law.

3



VERSIGENT PLC
CONDENSED COMBINED STATEMENTS OF OPERATIONS
(Unaudited)
 
Three Months Ended March 31,
 20262025
 (in millions)
Net sales$2,212 $2,024 
Operating expenses:
Cost of sales1,968 1,775 
Selling, general and administrative97 105 
Amortization— 
Restructuring 46 16 
Separation costs26 
Total operating expenses2,138 1,901 
Operating income74 123 
Interest expense(5)(2)
Other expense, net (1)(1)
Income before income taxes and equity income 68 120 
Income tax benefit (expense)(29)
Income before equity income 77 91 
Equity income, net of tax
Net income81 96 
Net income attributable to noncontrolling interest
Net income attributable to Versigent$78 $95 


4


VERSIGENT PLC
CONDENSED COMBINED BALANCE SHEETS
(Unaudited)
March 31,
2026
December 31,
2025
(Unaudited)
 (in millions)
ASSETS
Current assets:
Cash and cash equivalents$282 $276 
Accounts receivable, net1,829 1,567 
Inventories784 772 
Other current assets251 158 
Total current assets3,146 2,773 
Long-term assets:
Property, net896 901 
Operating lease right-of-use assets182 168 
Investments in affiliates142 143 
Intangible assets, net
Deferred tax assets402 384 
Other long-term assets134 109 
Total long-term assets1,763 1,712 
Total assets$4,909 $4,485 
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt$67 $58 
Accounts payable1,532 1,530 
Accrued liabilities676 578 
Total current liabilities2,275 2,166 
Long-term liabilities:
Long-term debt2,074 
Pension benefit obligations207 217 
Long-term operating lease liabilities137 130 
Other long-term liabilities73 121 
Total long-term liabilities2,491 471 
Total liabilities4,766 2,637 
Net parent equity:
Net parent investment164 1,925 
Accumulated other comprehensive loss(212)(268)
Total parent (deficit) equity(48)1,657 
Noncontrolling interest191 191 
Total invested equity143 1,848 
Total liabilities and invested equity$4,909 $4,485 


5


VERSIGENT PLC
CONDENSED COMBINED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended March 31,
 20262025
 (in millions)
Net cash provided by operating activities$36 $40 
Cash flows from investing activities:
Capital expenditures(66)(37)
Net cash used in investing activities(66)(37)
Cash flows from financing activities:
Net proceeds (repayments) under short-term debt agreements - outside parties(72)
Net proceeds under short-term debt agreements - related parties— 12 
Proceeds from issuance of senior notes and credit agreement, net of issuance costs2,063 — 
Cash distribution paid to Parent(1,900)— 
Net transfers (to) from Parent (130)39 
Dividend payments of consolidated affiliates to minority shareholders(4)— 
Net cash provided by (used in) financing activities38 (21)
Effect of exchange rate fluctuations on cash and cash equivalents(2)
Increase (decrease) in cash and cash equivalents(14)
Cash and cash equivalents at beginning of the period276 201 
Cash and cash equivalents at end of the period$282 $187 

6


VERSIGENT PLC
RECONCILIATION OF NON-GAAP MEASURES
(Unaudited)

In this press release the Company has provided information regarding certain non-GAAP financial measures, including “Adjusted Revenue Growth”, “Adjusted EBITDA” and “Free Cash Flow”. Such non-GAAP financial measures are reconciled to their closest GAAP financial measure in the following schedules.


Adjusted Revenue Growth: Adjusted Revenue Growth is presented as a supplemental measure of the Company’s financial performance which management believes is useful to investors in assessing the Company’s ongoing financial performance that, when reconciled to the corresponding U.S. GAAP measure, provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the Company’s core operating performance and which may obscure underlying business results and trends. Our management utilizes Adjusted Revenue Growth in its financial decision making process, to evaluate performance of the Company and for internal reporting, planning and forecasting purposes. Adjusted Revenue Growth is defined as the change in reported net sales relative to the comparable period, excluding the impact on net sales from currency exchange and commodity movements. Not all companies use identical calculations of Adjusted Revenue Growth, therefore this presentation may not be comparable to other similarly titled measures of other companies.

Three Months Ended March 31, 2026
Reported net sales % change%
Less: foreign currency exchange and commodities%
Adjusted revenue growth%



7


Adjusted EBITDA: Adjusted EBITDA is presented as a supplemental measure of the Company’s financial performance which management believes is useful to investors in assessing the Company’s ongoing financial performance that, when reconciled to the corresponding U.S. GAAP measure, provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the Company’s core operating performance and which may obscure underlying business results and trends. Our management utilizes Adjusted EBITDA in its financial decision-making process, to evaluate performance of the Company and for internal reporting, planning and forecasting purposes. Adjusted EBITDA is defined as net income (loss) before depreciation and amortization (including asset impairments), interest expense, income tax (expense) benefit, other income (expense), net, equity income (loss), net of tax, restructuring, separation costs related to the Spin-Off and other special items. Not all companies use identical calculations of Adjusted EBITDA, therefore this presentation may not be comparable to other similarly titled measures of other companies. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of net sales.

Three Months Ended March 31,
20262025
(in millions)
Net income attributable to Versigent$78$95
Interest expense 52
Income tax (benefit) expense (9)29
Net income attributable to noncontrolling interest 31
Depreciation and amortization 6152
EBITDA$138$179
Other expense, net11
Equity income, net(4)(5)
Restructuring4616
Separation costs 265
Net gain on lease terminations(4)
Other acquisition and portfolio project costs2
Adjusted EBITDA$203$198
Adjusted EBITDA Margin9.2 %9.8 %

Free Cash Flow: Free Cash Flow is presented as a supplemental measure of the Company’s liquidity, which is consistent with the basis and manner in which management presents financial information for the purpose of making internal operating decisions, evaluating its liquidity and determining appropriate capital allocation strategies. Management believes this measure is useful to investors to understand how the Company’s core operating activities generate and use cash. Free Cash Flow is defined as cash provided by (used in) operating activities less capital expenditures. Not all companies use identical calculations of Free Cash Flow, therefore this presentation may not be comparable to other similarly titled measures of other companies. The calculation of Free Cash Flow does not reflect cash used to service debt, pay dividends or repurchase shares and therefore, does not necessarily reflect funds available for investment or other discretionary uses.

Three Months Ended March 31,
20262025
(in millions)
Net cash provided by operating activities $36 $40 
Capital expenditures(66)(37)
Free cash flow$(30)$

8


Financial Guidance: The reconciliation of the forward-looking non-GAAP financial measures provided in the Company’s financial guidance to the most comparable forward-looking GAAP measure is below. The Company’s full year 2026 financial guidance reflects the impacts of currently imposed tariffs by the U.S. government, but does not reflect the impacts of the potential for additional tariffs, trade barriers or retaliatory actions by the U.S. or other countries.
Estimated Full Year
2026 (a)
(in millions)
Adjusted EBITDA
Net income attributable to Versigent$345 
Interest expense105 
Income tax expense100 
Net income attributable to noncontrolling interest 15 
Depreciation and amortization235 
EBITDA$800 
Other expense, net10 
Equity income, net of tax(15)
Restructuring115 
Separation costs and other special items80 
Adjusted EBITDA$990 
Adjusted EBITDA Margin10.7 %


Estimated Full Year
2026 (a)
(in millions)
Free Cash Flow
Net cash provided by operating activities$490 
Capital expenditures(240)
Free cash flow$250 

(a)
Prepared at the estimated mid-point of the Company’s financial guidance range.




Press contact:
Annalisa Esposito Bluhm, Vice President Corporate Communications and Marketing
Phone: +1.248.817.7990
email: mediarelations@versigent.com

Investor Relations:
email: ir@versigent.com


9

FAQ

How did Versigent (VGNT) perform financially in Q1 2026?

Versigent reported Q1 2026 revenue of $2,212 million, up 9% year over year, with adjusted growth of 3%. Net income attributable to Versigent was $78 million, down from $95 million, while Adjusted EBITDA reached $203 million with a 9.2% margin.

What 2026 financial guidance did Versigent (VGNT) reaffirm?

Versigent reaffirmed full-year 2026 guidance for revenue of $9,100–$9,400 million, U.S. GAAP net income of $315–$375 million, Adjusted EBITDA of $950–$1,030 million, operating cash flow of $440–$540 million, and free cash flow of $200–$300 million.

What new dividend policy did Versigent (VGNT) announce?

Versigent’s board approved a dividend policy intending to return a portion of future earnings with target quarterly dividends of about $0.13 per share. Dividends will only be paid when, as, and if declared by the board at future dates.

Did Versigent (VGNT) authorize a share repurchase program?

Yes. Versigent’s board approved a share repurchase program of up to $250 million of the company’s shares. The program has no expiration date and repurchases may occur over time at management’s discretion, subject to applicable laws and regulations.

How did Versigent’s profitability and margins trend in Q1 2026?

Versigent’s Q1 2026 net income attributable to the company was $78 million, down from $95 million a year earlier. Adjusted EBITDA was $203 million versus $198 million, but the Adjusted EBITDA margin declined from 9.8% to 9.2% amid higher restructuring and separation costs.

What was Versigent’s cash flow and free cash flow in Q1 2026?

In Q1 2026, Versigent generated $36 million of cash from operating activities and spent $66 million on capital expenditures. This resulted in free cash flow of $(30) million, which included $26 million of separation costs related to the spin-off from Aptiv.

How did Versigent’s balance sheet change after the spin-off financing?

As of March 31, 2026, Versigent reported long-term debt of $2,074 million and short-term debt of $67 million, up sharply from year-end 2025. The increase stems from issuing senior notes and entering a credit agreement in connection with the spin-off.

Filing Exhibits & Attachments

4 documents